+0.2%
TTD vs MRNA
+786.4%
-786.2%
-91.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -8.1% | -2.2% | -5.9% | -7.9% |
| 7D | -14.7% | -12.7% | -2.0% | -13.6% |
| 30D | +6.3% | -20.7% | +26.9% | +8.2% |
| 3M | +0.5% | +46.3% | -45.8% | -4.0% |
| 6M | -36.3% | +305.2% | -341.6% | -51.1% |
| YTD | -64.8% | +561.2% | -626.0% | -75.7% |
| 1Y | -65.1% | +772.1% | -837.2% | -77.2% |
| 3Y | -80.1% | +147.0% | -227.1% | -84.7% |
| 5Y | -87.6% | -26.1% | -61.5% | -88.8% |
| All | +0.2% | +786.4% | -786.2% | -25.6% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling